The rise of Sildenafil initially drove a period of growth for major pharmaceutical companies, however recent shifts present a uncertain scenario for those considering a stake. Generic versions are eroding earnings, and https://albertetaw142847.blogunteer.com/39894345/viagra-and-big-pharma-a-risky-play